ISSN: 1173-2563
Journal Home
Journal Guideline
Clinical Drug Investigation Q2 Unclaimed
Clinical Drug Investigation is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology (medical) with an H index of 67. It has a price of 2790 €. It has an SJR impact factor of 0,68 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,68.
Clinical Drug Investigation focuses its scope in these topics and keywords: treatment, perspective, costs, neuralgia, metastatic, locally, lapatinib, interaction, insomniasafety, infection, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
2790 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,68
SJR Impact factor67
H Index96
Total Docs (Last Year)332
Total Docs (3 years)2966
Total Refs860
Total Cites (3 years)305
Citable Docs (3 years)2.63
Cites/Doc (2 years)30.9
Ref/DocOther journals with similar parameters
Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2
Compare this journals
Aims and Scope
Best articles by citations
Early and Late Switch from Ranibizumab to an Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema in the Event of a Poor Anatomical Response
View moreIsoniazid and its Hydrazine Metabolite in Patients with Tuberculosis
View morePharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
View morePharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects
View moreAntihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals
View moreEvaluation of Stat Orders in a Teaching Hospital
View moreAdd-On Treatment with Pregabalin for Patients with Uncontrolled Neuropathic Pain Who Have Been Referred to Pain Clinics
View morePharmacology of Silymarin
View moreEffects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus
View moreAzilsartan Medoxomil
View moreAzilsartan Medoxomil
View moreReduction in Opioid-Related Adverse Events and Improvement in Function with Parecoxib followed by Valdecoxib Treatment after Non-Cardiac Surgery
View morePCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world Study
View moreLong-term Renal Effects of Tenofovir-Disoproxil-Fumarate in Vertically HIV-Infected Children, Adolescents, and Young Adults: A 132-Month Follow-Up Study
View moreLong-Term Renal Safety of Tenofovir Disoproxil Fumarate in Vertically HIV-Infected Children, Adolescents and Young Adults
View moreOral L-Ornithine-L-Aspartate Improves Health-Related Quality of Life in Cirrhotic Patients with Hepatic Encephalopathy
View moreEffect of Concomitant Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on the Pharmacokinetics of Atorvastatin
View moreRenal Safety of Tenofovir in HIV-infected Children
View moreResource Utilisation and Time Commitment Associated with Correction of Anaemia in Cancer Patients Using Epoetin Alfa
View moreEffects of Phenobarbital and Levetiracetam on PR and QTc Intervals in Patients with Post-Stroke Seizure
View moreSafety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation
View moreDefibrotide: A Review of Its Use in Severe Hepatic Veno-Occlusive Disease Following Haematopoietic Stem Cell Transplantation
View moreIdiopathic Breakthrough Pain
View morePharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain
View more
Comments